Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 26, 2008

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Combigan	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Iquix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Lipofen	New Drug Initial Review	Require Prior Approval	Prior Approval Required
ProAir HFA	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Saizen	PDL Appeal	Remain Non-Preferred	Non-Preferred � PDL Class
Sanctura XR	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Simcor	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tekturna	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vusion	New Drug Initial Review	Require Prior Approval	Prior Approval Required

Footer